Skip to main content
. 2018 Dec 3;64(5):1238–1256. doi: 10.1007/s10620-018-5395-7

Fig. 7.

Fig. 7

NASH pathology after drug treatment. a Representative images of hematoxylin–eosin stainings. b Composite NAFLD Activity Score (NAS). c Steatosis score. d Inflammation score. e Ballooning degeneration score. *P < 0.05, ***P < 0.001 versus CDAA + 1%chol vehicle